Short answer
Humacyte, Inc. (HUMA) filed an 8-K current report with the SEC on May 8, 2026 reporting Item 3.01 (Notice of Delisting). Nasdaq deficiency: HUMA closed below the $1.00 minimum bid requirement for 30 consecutive business days.
- This filing includes Item 3.01, an item that often signal trouble.
Humacyte, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.01 · Notice of Delisting
- Nasdaq deficiency: HUMA closed below the $1.00 minimum bid requirement for 30 consecutive business days
- Initial 180-day compliance period runs through November 2, 2026
- Regaining compliance requires a closing bid of at least $1.00 for 10 consecutive business days
- No immediate delisting: HUMA continues trading on Nasdaq Global Select Market
- Failure to recover creates delisting risk and potential liquidity and trading impacts for shareholders
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Humacyte, Inc. 8-K filings
Get the next HUMA 8-K as it lands
Follow HUMA for push alerts, or ask the research agent what this filing means.